Compare QTTB & AHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QTTB | AHRT |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | 98 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.1M | 539.3M |
| IPO Year | 2018 | 2013 |
| Metric | QTTB | AHRT |
|---|---|---|
| Price | $15.68 | $6.96 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $13.00 | $7.00 |
| AVG Volume (30 Days) | ★ 2.0M | 604.3K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 9.30% |
| EPS Growth | ★ 136.78 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $53,737,000.00 | N/A |
| Revenue This Year | N/A | $854.92 |
| Revenue Next Year | N/A | $11.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $5.13 |
| 52 Week High | $23.57 | $7.20 |
| Indicator | QTTB | AHRT |
|---|---|---|
| Relative Strength Index (RSI) | 54.11 | 52.53 |
| Support Level | $14.13 | $6.93 |
| Resistance Level | $23.57 | $7.19 |
| Average True Range (ATR) | 1.63 | 0.12 |
| MACD | -0.18 | -0.01 |
| Stochastic Oscillator | 13.67 | 41.51 |
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
AH Realty Trust Inc is a real estate investment trust (REIT). It owns, operates, and acquires high-quality properties across the Mid-Atlantic and Southeast, creating lasting value for investors, partners, clients, tenants, and communities. The group focuses on operating and acquiring high-quality, well-positioned assets with growth potential and delivering long-term value for shareholders. Its portfolio includes Harbor Point, Southern Post, The Interlock, and Others.